BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Beating The Odds; Growing Biobusinesses Today


4/29/2013 11:41:52 AM

April 2013 -- One day conference at Clare College, Cambridge, on 3rd October 2013

How do you build successful biobusinesses in these tough and fast-changing times? The Centre for Entrepreneurial Learning (CfEL) at Cambridge Judge Business School is working in partnership with independent consultant, Miranda Weston-Smith, and One Nucleus, the membership organisation for international life science and healthcare companies, to stage a one-day conference on 3rd October at Clare College in Cambridge to answer this question and more.

The conference will bring together a speaker line-up of leading women biobusiness leaders, from the UK and beyond, to inspire, debate and deliver fresh perspectives. This highlights women’s contribution to the sector but more importantly offers the opportunity to learn from and tap into female talent for the benefit of bio businesses.

Research studies such as Ernst and Young '2012 High Achievers: report' and RSA Report 'Women on Boards: A Life Sciences’ Perspective' have suggested that women adopt different strategies for business growth from novel ways of building companies and working in teams to raising funds and attitudes to risk. Understanding the success factors can pave the way for new business models that embrace diversity of talent, are more inclusive and people-centric, and so are more responsive to the fast-changing needs of the bio sector.

Current guest speakers and contributors include Dr Bahija Jallal, Executive Vice President MedImmune; Dr Helen Lee, Director of Research, Department of Haematology, University of Cambridge, Founder of Diagnostics for the Real World; Dr Julie Barnes, Chief Executive Officer, Abcodia; Dr Allison Jeynes-Ellis, Chief Medical Officer, Avillion; Dr Catherine Beech OBE, Chief Executive Officer, Oval Medical Technologies; Dr Deborah Harland, Partner SR One; Susan Searle, CEO, Imperial Innovations plc; Dr Anne Dobrée, Head, Cambridge Enterprise Seed Funds; and Dr Jane Osbourn, VP Research & Development and Head of Site, Cambridge MedImmune.

Miranda Weston-Smith commented: “We’ve had a tremendous response so far, not just from women who want to grow the industry but also from men who want to understand how diversity can work better in practice. This way, everyone wins.”

Harriet Fear, Chief Executive of One Nucleus, added: “We are delighted to be a key partner supporting this conference because its focus is about getting the sector to think about new, creative and improved ways to maximise global competitiveness – and this includes learning from women who have been there and who are doing it.”

Cambridge is home to Europe’s largest life science and healthcare cluster so a natural place to host a forum on current challenges and developments in the bio sector. The conference will explore new approaches and strategies for enterprise, funding and growth. It is a rare chance for bio entrepreneurs, industry experts, academics and students to attend, participate in meaningful discussions and network with those who want to be part of the next wave of bio innovation.

The conference partners are delighted to have the additional support of a range of organisations and student groups including St John’s Innovation Centre, the Humanitarian Centre, Oxbridge Biotech Roundtable, the Cambridge University Entrepreneurs (CUE); and the Cambridge University Technology Entrepreneurs Club (CUTEC).

Further information about the conference at the Gillespie Centre, Clare College, Cambridge, on 3rd October 2013, is available on the CfEL web site at http://www.cfel.jbs.cam.ac.uk/programmes/biobusiness/index.html

Places are limited so early booking is advisable to secure your place. Please note that fees apply. If you have any additional enquires or would like to discuss further, please contact Orsolya Ihasz, CfEL Programme Manager, or Miranda Weston-Smith. Email: biobusiness@jbs.cam.ac.uk

Media contact: Katharine Price, CfEL Marketing & Communications Manager; Tel: +44 (0)1223 766917; Email: k.price@jbs.cam.ac.uk

About the Centre for Entrepreneurial Learning (CfEL) www.cfel.jbs.cam.ac.uk

The Centre for Entrepreneurial Learning (CfEL), based at Cambridge Judge Business School, aims to spread the spirit of enterprise to both the University of Cambridge community and to wider national and international audiences through the creation and delivery of a range of educational activities that inspire and build skills in the practise of Entrepreneurship. One of CfEL's key teaching values is that the best people to teach entrepreneurs are entrepreneurs. This philosophy has led to the Centre collaborating with a network of over 300 experienced entrepreneurs, innovators and other practitioners to provide relevant, credible and practical training.

The Centre has developed an enviable track record in the field of entrepreneurship education with a number of flagship programmes designed to provide skills for students, graduates, researchers and aspiring entrepreneurs from different backgrounds and at different stages of the entrepreneurial journey. These programmes are Enterprise Tuesday, ETECH Projects, Ignite, Enterprisers and the Postgraduate Diploma in Entrepreneurship.

Tel: 01223 766900; Email: cfel@jbs.cam.ac.uk ; Web: www.cfel.jbs.cam.ac.uk

Miranda Weston-Smith

Miranda Weston-Smith founded Women in BioBusiness in partnership with the Centre for Entrepreneurial Learning, University of Cambridge, in 2012. The not-for-profit initiative will create a forum to inspire and support the next wave of entrepreneurs and leaders, which includes this conference. In addition, Miranda provides practical business development services for healthcare and biotech. She supports clients with marketing, new venture development and technology transfer expertise offering a cost-effective way to boost a company's growth. Visit Miranda’s website to find out more. http://mws-consulting.co.uk/

One Nucleus

Established in 1997, and formerly known as ERBI, One Nucleus is a not-for-profit, membership organisation owned by its members and located in Cambridge and London - the centre of Europe's leading life science and healthcare cluster. More than 470 members include pharmaceutical, biotech, medical device and diagnostic companies and associated technical and commercial service providers.

One Nucleus's mission is to maximise the global competitiveness of their members. For their science and technology-based members, that means being global leaders in the research, development and commercialisation of healthcare innovations that radically improve the quality of people's lives around the world. For their business and professional services members, it means delivering exceptional services that significantly enhance the business performance of their clients.

Holdsworth Associates PR consultancy

Century House, Market Street

Swavesey, Cambridge, CB24 4QG

Tel: 01954 202789

Email: Rachel@holdsworth-associates.co.uk

Web: www.holdsworth-associates.co.uk

Blog: http://blog.holdsworth-associates.co.uk

Twitter: @holdsworthPR



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES